KLOTHO Allele Status and the Risk of Early-Onset Occult Coronary Artery Disease  by Arking, Dan E. et al.
Am. J. Hum. Genet. 72:1154–1161, 2003
1154
KLOTHO Allele Status and the Risk of Early-Onset Occult Coronary
Artery Disease
Dan E. Arking,1 Diane M. Becker,2 Lisa R. Yanek,2 Daniele Fallin,4 Daniel P. Judge,3
Taryn F. Moy,2 Lewis C. Becker,4 and Harry C. Dietz1,5
1McKusick-Nathans Institute of Genetic Medicine, 2Center for Health Promotion, Division of Internal Medicine, and 3Division of Cardiology,
Johns Hopkins University School of Medicine, 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and
5Howard Hughes Medical Institute, Baltimore
We previously identified a functional variant of KLOTHO (termed “KL-VS”), which harbors two amino acid
substitutions in complete linkage disequilibrium and is associated with reduced human longevity when in homo-
zygosity. Klotho-deficient mice display extensive arteriosclerosis when fed a normal diet, suggesting a potent genetic
predisposition. To determine whether klotho influences atherosclerotic risk in humans, we performed cross-sectional
studies to assess the association between the KL-VS allele and occult coronary artery disease (CAD) in two inde-
pendent samples of apparently healthy siblings of individuals with early-onset (age !60 years) CAD (SIBS-I
[ ] and SIBS-II [ ]). Occult CAD was defined as the occurrence of a reversible perfusion defectNp 520 Np 436
during exercise thallium scintigraphy and/or as an abnormal result of an exercise electrocardiogram (SIBS-I,
; SIBS-II, ). In SIBS-I, the KL-VS allele conferred a relative odds of 1.90 (95% confidence intervalnp 97 np 56
1.21–2.98) for occult CAD, after adjusting for familial intraclass correlations ( ). Logistic regression mod-P ! .005
eling, incorporating known CAD risk factors, demonstrated that the KL-VS allele is an independent risk factor
( ) and that the imposed risk of KL-VS allele status is influenced by modifiable risk factors. HypertensionP ! .019
( ) and increasing high-density lipoprotein cholesterol (HDL-C) levels ( ) mask or reduce the riskP ! .022 P ! .022
conferred by the KL-VS allele, respectively, whereas current smoking ( ) increases the risk. RemarkablyP ! .004
concordant effects of the KL-VS allele and modifying factors on the risk of occult CAD were seen in SIBS-II. These
results demonstrate that the KL-VS allele is an independent risk factor for occult CAD in two independent high-
risk samples. Modifiable risk factors, including hypertension, smoking status, and HDL-C level, appear to influence
the risk imposed by this allele.
Introduction
We previously identified an allele of the gene KLOTHO
(MIM 604824), termed “KL-VS,” that is prevalent in
the general population (frequency 0.157) and, in ho-
mozygosity, is associated with reduced human longevity
(Arking et al. 2002). This allele is characterized by six
SNPs that occur within an 800-bp region spanning exon
2 and flanking sequence. Of the three mutations in exon
2, one is silent, and two code for amino acid substitu-
tions, F352V and C370S, that influence klotho metab-
olism. Klotho-deficient mice display extensive and ac-
celerated arteriosclerosis in association with medial
calcification of the aorta and both medial calcification
and intimal thickening of medium-sized muscular arter-
ies (Kuro-o et al. 1997). In addition, they exhibit im-
paired endothelium-dependent vasodilation, decreased
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levels of nitric oxide metabolites (NO2 and NO3) in
urine, and impaired angiogenesis, suggesting that klotho
protein may protect the cardiovascular system through
endothelium-derived nitric oxide production (Saito et al.
1998, 2000; Nagai et al. 2000; Fukino et al. 2002).
Remarkably, in a rat model with multiple atherogenic
risk factors (including hypertension, diabetes, obesity,
and hyperlipidemia), in vivo klotho gene delivery can
ameliorate vascular endothelial dysfunction and prevent
medial hypertrophy and perivascular fibrosis (Shiraki-
Iida et al. 2000).
Klotho is a member of the family 1 glycosidases and
is composed of two internal repeats, each of which ex-
hibits 20%–40% sequence identity to b-glucosidases
across phylogeny, as well as mammalian lactase phlor-
hizin hydrolase. However, an enzymatic substrate for
klotho has not been identified. Alternative RNA splicing
yields both membrane-bound and secreted forms of klo-
tho. In addition, klotho mRNA expression was not de-
tectable in many organs in which severe pathology oc-
curs in klotho-deficient mice. These observations and
parabiosis experiments have led to the hypothesis that
klotho acts as a humoral factor.
To determine whether KL-VS allele status influences
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risk of atherosclerotic coronary artery disease (CAD) in
humans and is related to known modifiable risk factors,
we employed cross-sectional association studies in two
independent samples of apparently healthy siblings of
hospitalized index cases with documented early-onset
(age !60 years) CAD. Subjects who appeared to be
healthy were chosen in order to enrich for factors that
predispose to atherosclerosis rather than for factors that
may trigger cardiac events.
Subjects and Methods
Study Population
The Johns Hopkins Sibling Study is an investigation
of risk factors and their relationship to occult and in-
cident CAD events in asymptomatic, apparently healthy
30–59-year-old siblings of individuals hospitalized with
documented CAD at !60 years of age. Siblings were
asked to participate in a comprehensive cardiovascular
screening protocol and were eligible if they were !60
years of age and had experienced no clinically manifest
CAD. Two separate samples were recruited using the
same methods and were screened identically. The first
sample (SIBS-I) was recruited in 1983–1996 from three
Baltimore hospitals. The second sample (SIBS-II) was
composed exclusively of African Americans and was re-
cruited in 1998–2001 from 10 Baltimore hospitals. Re-
cruitment methods were described in detail in a prior
publication (Becker et al. 1998). The study was ap-
proved by the Johns Hopkins institutional review board,
and all participating siblings gave informed consent.
Risk Factor Assessment
A cardiovascular history was taken, physical exami-
nation was performed, and blood was obtained for mea-
surement of fasting levels of plasma total cholesterol,
high-density lipoprotein cholesterol (HDL-C), and tri-
glycerides (TG) in the Johns Hopkins chemistry labora-
tory, which is standardized to the requirements of the
Centers forDisease Control. Low-density lipoprotein cho-
lesterol (LDL-C) was estimated using the Friedewald for-
mula for persons with TG levels !400 mg/dl (Friedewald
et al. 1972). For adjusted analysis (see below), individuals
with TG levels 1400mg/dl were assigned an averageLDL-
C for their race and sex ( ). Blood pressure wasnp 29
measured at standard intervals, according to American
Heart Association guidelines (1990), during an 8-h screen-
ing day. Three readings were averaged to characterize
blood pressure for all subjects. Hypertension was defined
as an average blood pressure of 140/90 mm Hg or the
current use of antihypertensive medication. Current
smoking status was defined by self-reported smoking of
any cigarettes within the past month and was validated
by measurement of expired carbon monoxide levels (18
ppm) (Morabia et al. 2001). BMIwas calculated asweight
in kilograms divided by the square of the height in meters.
Exercise Thallium Scintigraphy
All siblings underwent a maximal symptom-limited
graded exercise treadmill test (ETT), using a modified
Bruce protocol (Blumenthal et al. 1996). In men, a pos-
itive stress test was defined as horizontal or downsloping
ST-segment depression of 1 mm over baseline at 0.06
s after the J-point in 3 consecutive beats during the
stress test or during the first 3 min of recovery. In women
an abnormal response was defined as 2 mm flat or
downsloping ST-segment depression over baseline in
leads II, III, or AVF or as 1.5-mm ST-segment depres-
sion in any other lead.
Scintigraphy with thallium 201 was performed in con-
junction with the ETT, as described elsewhere (Blumen-
thal et al. 1996). In brief, 1 min before the end of exercise,
3–4 mCi thallium 201 was injected intravenously, and
tomographic imaging was begun 5–10 min later. After 4
h, delayed imaging was performed. Images were recon-
structed by filtered back-projection, using a ramp filter
after prefiltering of the projection images with a two-
dimensional Fourier (Weiner) filter and correction for
translational motion. Images were interpreted visually by
an experienced nuclear cardiologist (L.C.B.), who had
no knowledge of the subject’s identity, genotype, or risk
factors.
Occult CAD was defined as an abnormal thallium
tomography test represented by a segmental perfusion
defect on the immediate postexercise images in more
than two contiguous tomographic slices and two image
orientations, accompanied by definite improvement or
normalization on the delayed images. When receiver-
operating-curve analysis is used, the visual interpretation
using these criteria provides a 95% sensitivity for de-
tection and a false-positive rate !10% (Fintel et al.
1989). The presence of perfusion defects is strongly as-
sociated with subsequent occurrence of premature CAD
in the SIB-I population (Blumenthal et al. 1996).
KL-VS Screening
After DNA was extracted from whole blood buffy
coat preparations or Guthrie cards, according to stan-
dard protocols, sample DNA was amplified using PCR
(sense primer 5′-AGGCTCATGCCAAAGTCTGG-3′;
antisense primer 5′-GTTTCCATGATGAACTTTTTG-
AGG-3′) with AmpliTaq Gold (Perkin Elmer) and sup-
plied buffer under the following conditions: 95C for 10
min, followed by 35 cycles of 94C for 30 s, 60C for 30
s, and 72C for 30 s, followed by a 10-min 72C final
extension. PCR products were then digested withMaeIII
(Roche) at 55C for 16 h and were electrophoretically
separated on a 1.6% agarose gel. The KL-VS allele is
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Table 1
Risk Factors and Demographic Characteristics Stratified by Sample and the Presence or Absence of Occult CAD
OCCULT CAD IN SIBS-I OCCULT CAD IN SIBS-II
VARIABLE
Absent
(n p 423)
Present
(n p 97) Pa
Absent
(n p 380)
Present
(n p 56) Pa
Continuous (mean  SD):
Age (years) 45.3  7.1 48.7  7.0 .0001 47.0  6.7 49.0  6.3 .0367
HDL-C (mg/dl) 51.4  16.0 46.4  14.9 .0050 54.4  16.9 53.8  15.9 .7939
LDL-C (mg/dl) 147.4  42.7 162.3  44.7 .0021 129.1  39.2 136.2  39.4 .2021
TG (mg/dl) 149.1  123.8 194.3  208.7 .0426 123.5  84.7 109.5  57.9 .1184
Systolic BP (mm Hg) 130.6  14.2 138.8  14.5 .0001 135.5  16.6 139.8  12.6 .0236
Diastolic BP (mm Hg) 83.3  9.4 87.7  9.0 .0001 86.5  10.5 88.0  8.3 .2347
BMI 27.6  5.8 28.5  3.8 .0478 31.9  6.9 29.7  5.4 .0064
Qualitative (%):
Diabetes 6.4 3.1 .2116 15.0 14.3 .8886
Hypertension 39.6 54.6 .0069 58.9 67.9 .2037
Current Smokers 31.1 28.9 .6625 31.6 32.1 .9325
African American 16.0 13.4 .5181 100 100 …
Male 46.5 76.3 .0001 30.3 64.3 .0001
a Analysis using t tests or x2 tests comparing occult CAD status groups within each sample.
characterized by diagnostic MaeIII restriction fragments
of 265 and 185 bp.
Statistical Analysis
Descriptive statistics for each risk variable included
means SD (continuous variables) or frequencies (qual-
itative variables) calculated separately for siblings found
to have occult CAD and those without CAD. Unadjusted
univariate comparisons between groups were performed
via Shapiro-Wilk tests or the x2 statistic in SAS, version
8.2 (SAS Institute). Adjusted analyses for KL-VS allele
status and interactive effects were performed via general
linear modeling using PROC GENMOD in SAS (em-
ploying a log-link function to reflect logistic regression)
and using generalized estimating equations (GEE) (Liang
and Zeger 1993) to account for the familial intraclass
correlations between siblings when obtaining parameter
estimates and variances. Because of the limited number
of KL-VS homozygotes, adjusted analyses that include
more than one interaction term assumed a dominant
genetic model in comparisons of KL-VS carriers with
noncarriers. The influence of modifiable risk factors on
the risk conferred by KL-VS allele status was evaluated
via the inclusion of interaction terms, and the signifi-
cance was assessed via likelihood ratio testing. Odds
ratios and CIs were obtained via GEE methods.
Results
The characteristics of the study population shown in
table 1 are stratified by the independent samples (SIBS-
I and SIBS-II) and by occult CAD status. SIBS-I (np
) was predominantly white, and SIBS-II ( )520 np 436
was exclusively African American. The study population
was middle-aged, and individuals with occult CADwere
slightly but significantly older in both SIBS samples.
Overall, the risk factors were generally more prevalent
in persons with occult CAD, and the differences in levels
and prevalence that were observed between SIBS-I and
SIBS-II likely reflect racial composition and socioeco-
nomic factors (Becker et al. 1998; Clark 1999).
Having previously identified a functional variant of
klotho (termed “KL-VS”) involved in human survival
(Arking et al. 2002), we wanted to determine whether
this allele also influences the risk of early-onset occult
CAD. Both SIBS-I and SIBS-II have KL-VS allele fre-
quencies (0.153 and 0.164, respectively) similar to that
seen in previous studies (Arking et al. 2002). Figure 1
shows the frequency of occult CAD in SIBS-I stratified
by KL-VS genotype. Univariate logistic regression anal-
ysis, assuming an additive genetic model (on a logit
scale) and incorporating a GEE adjustment for familial
intraclass correlations, indicates a relative odds of 1.90
(95% CI 1.21–2.98) for occult CAD conferred by the
KL-VS allele ( ). To test whether KL-VS alleleP ! .005
status is an independent risk factor, we constructed a
logistic regression model (LRM) incorporating known
CAD risk factors. Addition of KL-VS allele status
significantly improved the model after adjustment for
age, sex, race, BMI, hypertension, HDL-C level, LDL-
C level, TG level, diabetes, and current smoking status
( ), indicating that KL-VS allele status is a novelP ! .019
risk factor for occult atherosclerosis in this sample.
Experimental data in rats have demonstrated that
klotho mRNA and protein levels are down-regulated
under sustained circulatory stress (Aizawa et al. 1998;
Nagai et al. 2000). It is therefore plausible that hyper-
tensive conditions in humans could also lead to global
down-regulation of klotho. In this view, the presence of
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Figure 1 Frequency of occult CAD in the SIBS-I sample, strat-
ified by KLOTHO genotype. for trend (unadjusted). ErrorPp .002
bars indicate 95% CIs.
Figure 2 Frequency of occult CAD in the SIBS-I sample, strat-
ified by hypertension and KLOTHO genotype. Left, Normotensive
individuals. Right, Hypertensive individuals. Heterozygous and ho-
mozygous KL-VS allele carriers were combined because of the small
numbers in the latter group after stratification for hypertension. Error
bars indicate 95% CIs.
concomitant hypertension could modify the risk im-
posed by the KL-VS allele, which is believed to manifest
relative loss of functional klotho. Incorporation of an
interaction term (klotho*hypertension) into the LRM
to test whether hypertension modifies the risk associated
with the KL-VS allele significantly improved the model
( ) and indicates that the detrimental effect ofP ! .022
the KL-VS allele is more pronounced in normotensive
individuals (fig. 2 and table 2).
The possibility that additional modifiable risk factors
influence the association between KL-VS allele status and
occult atherosclerosis was analyzed by sequentially in-
corporating the risk factor interaction term that most
significantly improved the LRM ( ). The klothoP ! .05
term is incorporated under the assumption of a dominant
model, because of an insufficient number of homozygotes
for analysis under the assumption of an additive model.
Following this strategy, we found significant modifica-
tions to the risk associated with KL-VS allele status for
current smoking status ( ) (fig. 3 and table 2) andP ! .004
HDL-C levels ( ) (table 2). The addition of KL-P ! .022
VS allele status, including the modifications of risks due
to hypertension, smoking, and HDL-C levels, resulted in
a highly significant increase in the overall fit of the LRM
( ) and indicate a relative odds 9.8 (95% CIP ! .0002
3.27–29.6) for occult CAD among normotensive smok-
ers with HDL-C levels 40 mg/dl who carry the KL-VS
allele versus noncarriers (fig. 4).
We analyzed an additional sample (SIBS-II), in which
enrollment was limited to African Americans recruited
under the same criteria as the SIBS-I sample (table 1).
Univariate logistic regression analysis did not indicate
an increased risk of occult CAD for carriers of the KL-
VS allele (data not shown). This result was somewhat
predictable, given the higher frequency of hypertension
and the higher HDL levels in SIBS-II. However, inclu-
sion of KL-VS allele status in an LRM constructed to
incorporate known risk factors and risk modifications
due to hypertension and HDL-C level significantly im-
proved the ability to predict individuals with occult
CAD in SIBS-II ( ), as was observed in SIBS-IP ! .06
( ) (table 2). These results are particularly strik-P ! .0002
ing when one takes into account the remarkable simi-
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Table 2
Multiple Logistic Regression Predicting Occult CAD for SIBS-I and SIBS-II Samples
SIBS-I SIBS-II
RISK FACTORa bb SE P bb SE P
Intercept 9.2071 1.7987 .0001 3.0780 1.9622 .12
Age .0971 .0238 .0001 .0512 .0302 .09
Sex 1.4290 .3709 .0001 1.2623 .3292 .0001
Race .0690 .3985 .86 … … …
LDL-C .0062 .0034 .30 .0077 .0046 .10
HDL-C .0190 .0121 .12 .0040 .0153 .79
TG .0010 .0007 .17 .0046 .0030 .13
Diabetes 1.0038 .6767 .14 .5087 .5145 .32
Hypertension .5211 .3404 .13 .4938 .4703 .29
BMI .0478 .0278 .09 .0585 .0351 .10
Smoking .4201 .4039 .30 .0885 .4470 .84
Klotho 2.4170 1.0447 .021 2.6908 1.3959 .05
Klotho*hypertension .9834 .5851 .09 1.2558 .7344 .09
Klotho*smoking 1.4019 .6477 .030 .0048 .7282 .99
Klotho*HDL-C .0383 .0210 .07 .0341 .0212 .11
Overall klotho effectc .0002 .06
NOTE.—Analyses were GEE adjusted.
a Klotho is incorporated under the assumption of a dominant model.
b Underlined values show dramatic concordance between the SIBS-I and SIBS-
II populations.
c Likelihood ratio tests comparing models that included klotho and significantmodifier
terms with models that did not include klotho terms.
larity in the magnitude of effect attributable to the KL-
VS allele and significant modifying risk factors in the
two groups (table 2). Current smoking status had no
effect on the risk of occult CAD conferred by the KL-
VS allele in the SIBS-II population ( ). In SIBS-II,P 1 .99
the relative odds for occult CAD is 3.8 (95% CI
1.29–10.9) among normotensive individuals withHDL-
C levels 40 mg/dl who carry the KL-VS allele versus
noncarriers (fig. 4). These results confirm that KL-VS
allele status is an important predictor of occult CAD in
family members of individuals with early-onset, clini-
cally manifest CAD. However, modification of the risk
conferred by the KL-VS allele by known CAD risk fac-
tors may not be identical in all populations.
Discussion
Family history of premature CAD in a first-degree rel-
ative is a major predictor of CAD, even after adjustment
for known risk factors, suggesting the presence of as yet
unidentified genetic contributors to this complex disease
(Shea et al. 1984; Schildkraut et al. 1989; Yuhanna et
al. 2001). In a study reported elsewhere (Arking et al.
2002), we identified the KL-VS allele of the KLOTHO
gene as a functional variant that influences longevity,
and we demonstrated that the derived protein likely has
reduced activity. Individuals who are homozygous for
this allele exhibit a 2.6-fold reduction in survival to age
65 years. Partly on the basis of observations in klotho-
deficient mice, a role for klotho in protecting the car-
diovascular system has been proposed (Saito et al. 1998;
Nagai et al. 2000). We have now demonstrated that the
KL-VS allele of KLOTHO confers risk of occult ath-
erosclerosis in a high-risk sample composed of siblings
of individuals with premature CAD. The effect of the
KL-VS allele is evident after adjustment for known risk
factors (including sex), which indicates that it is a novel
risk factor for both men and women. Modifiable risk
factors, including hypertension, current smoking, and
HDL-C level, significantly modulated the risk associated
with the KL-VS allele. To confirm these results, we an-
alyzed an additional independent sample. We did not
see a univariate klotho effect in this sample, owing to
the increased levels of HDL-C and prevalence of hyper-
tension in its members. These factors mitigate the con-
tribution of the KL-VS allele to increased risk of occult
CAD. However, in an LRM, we did observe striking
similarities in klotho and klotho*HDL/hypertension
modifier effects between the two samples.
The identification of modifiable factors that are
known to influence the risk conferred by the KL-VS
allele is of particular interest, because these factors may
shed light on the mechanism by which klotho influences
atherogenic CAD risk and may suggest productive strat-
egies for therapeutic intervention. Hypertension and
HDL-C levels significantly modified the risk associated
with KL-VS allele status in both samples. Normotensive
KL-VS carriers demonstrated a greater increase in risk
of occult atherosclerosis than did hypertensive carriers.
Experimental data generated in rat models demonstrate
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Figure 3 Frequency of occult CAD in the SIBS-I sample, strat-
ified by KLOTHO genotype and current smoking status. Heterozy-
gous and homozygous KL-VS allele carriers were combined because
of the small numbers in the latter group after stratification for current
smoking status. Error bars represent 95% CIs.
that klotho levels are down-regulated under hyperten-
sive conditions (Aizawa et al. 1998; Nagai et al. 2000)
and by angiotensin II (Mitani et al. 2002). Thus, the
levels of klotho are likely to be reduced in hypertensive
individuals, which could mask the detrimental effect of
the KL-VS allele. This hypothesis also raises the intrigu-
ing question of whether the status of elevated angio-
tensin II as an independent risk factor for cardiovascular
disease (Brunner 2001; Gavras and Gavras 2002) may
be due, at least in part, to down-regulation of klotho
levels. Because a system for measuring serum levels of
klotho has not yet been developed, this hypothesis re-
mains to be tested. Alternatively, the modification, as a
result of hypertension, of the risk conferred by the KL-
VS allele could arise if hypertensive individuals who
carry the KL-VS allele exhibit greatly increased fre-
quency of coronary events, because only individuals
who are apparently unaffected were included in the pre-
sent study. Similarly, a differential response, depending
on KL-VS genotype, to antihypertensive medication
could contribute to this result. Prospective studies are
required to address these hypotheses.
Klotho has been proposed to protect the cardiovas-
cular system through endothelium-derived nitric oxide
production (Saito et al. 1998, 2000; Nagai et al. 2000;
Fukino et al. 2002), suggesting that the KL-VS allele
may increase the risk of occult CAD, at least in part,
because of a decrease in nitric oxide production. Thus,
in light of recent evidence that HDL-C activates en-
dothelial nitric oxide synthase and increases nitric oxide
expression (Yuhanna et al. 2001; Kuvin et al. 2002), it
is particularly intriguing that increased HDL-C levels
specifically protect against the detrimental effect asso-
ciated with the KL-VS allele. These data are consistent
with a model that invokes opposing influences of klotho
deficiency and elevated HDL-C levels on nitric oxide
production and ultimate risk of CAD. This result raises
the possibility that the use of drugs such as statins or
niacin to increase HDL-C levels may prove to be par-
ticularly effective in preventing CAD in KL-VS carriers
and that such an intervention might be beneficial even
in individuals with normal HDL-C levels.
CAD has been proposed to be subject to inter-
action between environmental factors and genetic
predispositions. Several studies have shown a relation-
ship between genetic factors and lifestyle choices such
as diet (McCombs et al. 1994; Ordovas 1999; Denke
et al. 2000) and alcohol consumption (Hines et al.
2001). Recently, Talmud et al. (2000) identified an allele
of lipoprotein lipase that augments risk of ischemic
heart disease, specifically in male smokers.We have now
demonstrated that KL-VS carriers who smoke exhibit
increased risk of occult CAD in the SIBS-I sample, in-
dicative of a strong gene-environment interaction. This
result was not seen in the SIBS-II sample, which is re-
stricted to African Americans. It is possible that the
marked increase in other risk factors in the SIBS-II sam-
ple (including diabetes, high BMI, and hypertension)
may mask any influence of smoking on the risk con-
ferred by the KL-VS allele. In addition, smoking habits
(including starting age and number of cigarettes per day)
and the stability of metabolites in the bloodstream in
African Americans are distinct from those in white
Americans (Ahijevych 1999; Woods et al. 2001). Fur-
ther studies are required to determine whether smoking
modifies the risk conferred by KL-VS allele status in
other populations and whether racial differences and/
or smoking habits modify this effect.
We deliberately studied apparently healthy siblings of
individuals with premature incident CAD, to enrich for
subjects with a genetic predisposition to CAD. Although
this study design was successful and may serve as a
model for identifying genetic contributions to CAD, the
extent to which the KL-VS allele contributes to occult
atherosclerotic CAD in the general population remains
to be elucidated.
In conclusion, we have identified a novel genetic risk
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Figure 4 Relative odds of occult CAD conferred by the KL-VS allele with increasing HDL-C Levels. Blackened squares represent SIBS-I
normotensive smokers. Closed triangles represent all SIBS-II normotensive individuals.
factor for early-onset CAD. The KL-VS allele of the
KLOTHO gene displays a strong gene-environment in-
teraction, and the risk associated with this allele is mod-
ulated by modifiable risk factors. Importantly, ∼25%
of individuals are carriers of this allele. These results
suggest that genotyping for the KL-VS allele will identify
individuals who are at higher relative odds of CAD and
who could benefit from a genetically tailored therapeu-
tic strategy.
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